Peter H. Stone, MD
Requests for Single Reprints: Peter H. Stone, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115; e-mail, firstname.lastname@example.org.
Stone PH. Update in Cardiology. Ann Intern Med. 2003;138:482-487. doi: 10.7326/0003-4819-138-6-200303180-00013
Download citation file:
Published: Ann Intern Med. 2003;138(6):482-487.
This Update looks back at a most exciting year in cardiology and anticipates novel therapeutic approaches. Topics discussed are unstable coronary artery disease; treatments of chronic coronary artery disease; risk factors for atherosclerotic cardiovascular disease, notably C-reactive protein; management of heart failure; and a potpourri of cardiovascular issues, including valvular disease, peripheral vascular disease, and arrhythmia.
Roughly 1.5 million hospital admissions each year in the United States result from unstable angina or non–ST-segment elevation myocardial infarction. A reliable way of stratifying risk among these patients would permit those more likely to develop adverse cardiac events to receive costly invasive treatments in a timely manner. Those at lower risk could safely be managed more conservatively—and less expensively. The cardiac troponins I and T, which have prognostic value in patients with unstable angina or non–ST-segment elevation myocardial infarction, might serve this purpose.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only